Oxford, UK, 8 January 2010 -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), recently announced the launch of the new special order BD LSRFortessa™ cell analyser, a powerful compact system that provides life science researchers with the ability to conduct complex multicolour flow cytometry experiments.
"Our special order research products programme combines the knowledge gained from decades of working closely with leading researchers and excelling in manufacturing," said Carolyn James, Business Director, UK and Ireland, BD Biosciences. "It allows us to work closely with customers to configure a BD LSRFortessa system that meets their exact specifications."
The BD LSRFortessa system offers power and flexibility in a benchtop footprint that is significantly smaller than the industry leading BD™ LSR II cell analyser. It is the only compact cell analyser that supports up to five lasers. Researchers can choose from 30 positions for detectors and 11 laser wavelengths and multiple power options to detect up to 18 colours simultaneously. Working with BD Biosciences’ flow cytometry experts, laboratories can configure a system that meets their precise research assay requirements.
"Space is at a premium in most research settings, leading many labs to compromise system power and performance because of space limitations," said James. "The new BD LSRFortessa system eliminates the need for that sacrifice by addressing researchers’ growing analytical needs and helping to maximise lab space utilisation at the same time."
The BD LSRFortessa system is the newest addition to the proven line of BD™ LSR cell analysers. The original BD LSR II system supports up to seven lasers and has been the preferred tool of life science researchers worldwide working in core, academic, pharmaceutical and biotechnology laboratories.
For more information about the BD LSRFortessa cell analyser, as well as the complete BD LSR product line, please visit: http://www.bdbiosciences.com/lsr.
Contacts:
Vikki Lomas
Corporate Communications
T: 01865 781607 About BD BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com/uk Receiver log in area: RealWire offers an online facility for receivers of news to view and amend details, news preferences and news delivery options. The receiver area also offers you access to a single RSS feed that is unique to you, based on your news preferences. Please visit www.realwire.com/receivers to log in, or www.realwire.com/receiveSignup.asp to request access details. RealWire also offers industry specific Twitter feeds - see http://www.realwire.com/twitter/. Database subscription:
RealWire aims to provide a targeted distribution through our RealWire service to editorial contacts. If you feel that releases received have not been well targeted and relevant to your areas of interest, please let us know and we will work to ensure this is corrected. If you wish to be unsubscribed, please reply to this release email and we will remove you immediately.
Corporate Communications
T: 01865 781607 About BD BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com/uk Receiver log in area: RealWire offers an online facility for receivers of news to view and amend details, news preferences and news delivery options. The receiver area also offers you access to a single RSS feed that is unique to you, based on your news preferences. Please visit www.realwire.com/receivers to log in, or www.realwire.com/receiveSignup.asp to request access details. RealWire also offers industry specific Twitter feeds - see http://www.realwire.com/twitter/. Database subscription:
